Review



m cxcl10 ip 10 goat igg  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems m cxcl10 ip 10 goat igg
    M Cxcl10 Ip 10 Goat Igg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 63 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+mouse+cxcl10/Mouse+CXCL10%2FIP-10%2FCRG-2+Antibody/pmc13107548-139-8-11
    Average 93 stars, based on 63 article reviews
    m cxcl10 ip 10 goat igg - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis.
    Article Snippet: Frozen brain tissue sections were incubated at 60 C for 20min, washed with PBS, then blocked with Protein block solution (X0909, DAKO) for 20min. .. Slides were incubated for 1.5h at RT with rabbit anti-mouse GFAP (Z-0334, Agilent), goat anti-mouse CXCL10 (AF-466-NA, R&D) or rat anti-mouse CD3 (MCA500GA, Bio-Rad), diluted 1:1000, 1:100, and 1:100, respectively. ..

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: .. Staining for Ly6G, F4/80, CD8 and CXCL10 was performed using the following primary antibodies incubated overnight at 4°C: rat anti-mouse Ly6G (1:200; 127632, BioLegend, San Diego, CA, USA) and rat anti-mouse F4/80 (1:500; #MCA497GA, Biorad, Hercules, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems), rabbit anti-mouse CD8 (1:500, Bioss #bs-0648R). .. As secondary antibodies, goat-anti rabbit IgG-biotin (1:200; #B2770, Life Technologies, Carlsbad, CA, USA) and goat anti-rat IgG-biotin (1:100 and 1:200 respectively for Ly6G and F4/80 staining; A10517, Invitrogen, Carlsbad, CA, USA) were used and incubated at room temperature (RT) for 30 min or 1 h, respectively.

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: NovaRED (#SK-4800, Vector® NovaRED® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Frontiers in Immunology 03 Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice.
    Article Snippet: .. Immunofluorescence staining for Mcpt5, ERα, Mdk, CXCL10, and Avidin was performed using the following antibodies: rabbit anti- mouse MC Protease 5 (1:100; #orb11030, Biorbyt) incubated overnight at 4 C, rabbit anti-mouse ERα (1:50; #PA5-16440, Invitrogen) incubated at RT for 2 hours, rabbit anti-mouse Mdk (1:100; #MBS714488, MyBioSource, San Diego, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D Systems), and Avidin Texas Red (1:150 for ERα and 1:200 for Mdk and CXCL10 staining; A820, Thermo Fisher Scientific, Waltham, MA, USA) incubated at RT for 1 hour. .. Donkey anti-rabbit Alexa Fluor 488 (#21206, Life Technologies) was used in a concentration of 1:2000 and 1:100, respectively, for Mcpt5 and both ERα and Mdk staining as the secondary antibody and incubated at RT for 1 hour.

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: NovaRED (#SK-4800, Vector ® NovaRED ® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: .. Staining for Ly6G, F4/80, CD8 and CXCL10 was performed using the following primary antibodies incubated overnight at 4°C: rat antimouse Ly6G (1:200; 127632, BioLegend, San Diego, CA, USA) and rat anti-mouse F4/80 (1:500; #MCA497GA, Biorad, Hercules, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems), rabbit anti-mouse CD8 (1:500, Bioss #bs-0648R). .. As secondary antibodies, goat-anti rabbit IgG-biotin (1:200; #B2770, Life Technologies, Carlsbad, CA, USA) and goat anti-rat IgG-biotin (1:100 and 1:200 respectively for Ly6G and F4/80 staining; A10517, Invitrogen, Carlsbad, CA, USA) were used and incubated at room temperature (RT) for 30 min or 1 h, respectively.

    Staining:

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: .. Staining for Ly6G, F4/80, CD8 and CXCL10 was performed using the following primary antibodies incubated overnight at 4°C: rat anti-mouse Ly6G (1:200; 127632, BioLegend, San Diego, CA, USA) and rat anti-mouse F4/80 (1:500; #MCA497GA, Biorad, Hercules, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems), rabbit anti-mouse CD8 (1:500, Bioss #bs-0648R). .. As secondary antibodies, goat-anti rabbit IgG-biotin (1:200; #B2770, Life Technologies, Carlsbad, CA, USA) and goat anti-rat IgG-biotin (1:100 and 1:200 respectively for Ly6G and F4/80 staining; A10517, Invitrogen, Carlsbad, CA, USA) were used and incubated at room temperature (RT) for 30 min or 1 h, respectively.

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: NovaRED (#SK-4800, Vector® NovaRED® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Frontiers in Immunology 03 Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice.
    Article Snippet: .. Immunofluorescence staining for Mcpt5, ERα, Mdk, CXCL10, and Avidin was performed using the following antibodies: rabbit anti- mouse MC Protease 5 (1:100; #orb11030, Biorbyt) incubated overnight at 4 C, rabbit anti-mouse ERα (1:50; #PA5-16440, Invitrogen) incubated at RT for 2 hours, rabbit anti-mouse Mdk (1:100; #MBS714488, MyBioSource, San Diego, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D Systems), and Avidin Texas Red (1:150 for ERα and 1:200 for Mdk and CXCL10 staining; A820, Thermo Fisher Scientific, Waltham, MA, USA) incubated at RT for 1 hour. .. Donkey anti-rabbit Alexa Fluor 488 (#21206, Life Technologies) was used in a concentration of 1:2000 and 1:100, respectively, for Mcpt5 and both ERα and Mdk staining as the secondary antibody and incubated at RT for 1 hour.

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: NovaRED (#SK-4800, Vector ® NovaRED ® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: .. Staining for Ly6G, F4/80, CD8 and CXCL10 was performed using the following primary antibodies incubated overnight at 4°C: rat antimouse Ly6G (1:200; 127632, BioLegend, San Diego, CA, USA) and rat anti-mouse F4/80 (1:500; #MCA497GA, Biorad, Hercules, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems), rabbit anti-mouse CD8 (1:500, Bioss #bs-0648R). .. As secondary antibodies, goat-anti rabbit IgG-biotin (1:200; #B2770, Life Technologies, Carlsbad, CA, USA) and goat anti-rat IgG-biotin (1:100 and 1:200 respectively for Ly6G and F4/80 staining; A10517, Invitrogen, Carlsbad, CA, USA) were used and incubated at room temperature (RT) for 30 min or 1 h, respectively.

    Immunofluorescence:

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: NovaRED (#SK-4800, Vector® NovaRED® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Frontiers in Immunology 03 Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice.
    Article Snippet: .. Immunofluorescence staining for Mcpt5, ERα, Mdk, CXCL10, and Avidin was performed using the following antibodies: rabbit anti- mouse MC Protease 5 (1:100; #orb11030, Biorbyt) incubated overnight at 4 C, rabbit anti-mouse ERα (1:50; #PA5-16440, Invitrogen) incubated at RT for 2 hours, rabbit anti-mouse Mdk (1:100; #MBS714488, MyBioSource, San Diego, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D Systems), and Avidin Texas Red (1:150 for ERα and 1:200 for Mdk and CXCL10 staining; A820, Thermo Fisher Scientific, Waltham, MA, USA) incubated at RT for 1 hour. .. Donkey anti-rabbit Alexa Fluor 488 (#21206, Life Technologies) was used in a concentration of 1:2000 and 1:100, respectively, for Mcpt5 and both ERα and Mdk staining as the secondary antibody and incubated at RT for 1 hour.

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: NovaRED (#SK-4800, Vector ® NovaRED ® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Double Staining:

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: NovaRED (#SK-4800, Vector® NovaRED® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Frontiers in Immunology 03 Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: NovaRED (#SK-4800, Vector ® NovaRED ® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Avidin-Biotin Assay:

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: NovaRED (#SK-4800, Vector® NovaRED® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Frontiers in Immunology 03 Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice.
    Article Snippet: .. Immunofluorescence staining for Mcpt5, ERα, Mdk, CXCL10, and Avidin was performed using the following antibodies: rabbit anti- mouse MC Protease 5 (1:100; #orb11030, Biorbyt) incubated overnight at 4 C, rabbit anti-mouse ERα (1:50; #PA5-16440, Invitrogen) incubated at RT for 2 hours, rabbit anti-mouse Mdk (1:100; #MBS714488, MyBioSource, San Diego, CA, USA), goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D Systems), and Avidin Texas Red (1:150 for ERα and 1:200 for Mdk and CXCL10 staining; A820, Thermo Fisher Scientific, Waltham, MA, USA) incubated at RT for 1 hour. .. Donkey anti-rabbit Alexa Fluor 488 (#21206, Life Technologies) was used in a concentration of 1:2000 and 1:100, respectively, for Mcpt5 and both ERα and Mdk staining as the secondary antibody and incubated at RT for 1 hour.

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: NovaRED (#SK-4800, Vector ® NovaRED ® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Concentration Assay:

    Article Title: Altered early immune response after fracture and traumatic brain injury.
    Article Snippet: NovaRED (#SK-4800, Vector® NovaRED® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Frontiers in Immunology 03 Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..

    Article Title: Altered early immune response after fracture and traumatic brain injury
    Article Snippet: NovaRED (#SK-4800, Vector ® NovaRED ® Substrate Kit, Peroxidase (HRP), Vector laboratories) was used as chromogen and the sections were counterstained with hematoxylin (1:2000; #2C-306, Waldeck, Münster, Germany). .. Immunofluorescence double staining for CXCL10 and Avidin was performed using the following antibodies: goat anti-mouse CXCL10 (1:50; #AF-466-NA, R&D systems) and Avidin Texas Red (1:150 A820, ThermoFisher) incubated at RT for 1 h. Rabbit anti-goat IgG (H+L) FITC (#A16143, Life Technologies) was used in a concentration of 1:50 for CXCL10 staining as the secondary antibody. ..



    Similar Products

    93
    R&D Systems m cxcl10 ip 10 goat igg
    M Cxcl10 Ip 10 Goat Igg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+mouse+cxcl10/Mouse+CXCL10%2FIP-10%2FCRG-2+Antibody/pmc13107548-139-8-11
    Average 93 stars, based on 1 article reviews
    m cxcl10 ip 10 goat igg - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems goat anti cxcl 10
    Goat Anti Cxcl 10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+mouse+cxcl10/Mouse+CXCL10%2FIP-10%2FCRG-2+Antibody/pm41527095-124-55-60
    Average 93 stars, based on 1 article reviews
    goat anti cxcl 10 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems goat anti cxcl10
    Goat Anti Cxcl10, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+mouse+cxcl10/Mouse+CXCL10%2FIP-10%2FCRG-2+Antibody/pmc12148934-266-90-92
    Average 93 stars, based on 1 article reviews
    goat anti cxcl10 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems anti mouse igg goat polyclonal
    Anti Mouse Igg Goat Polyclonal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+mouse+cxcl10/Human+CXCL10%2FIP-10%2FCRG-2+Antibody/med_rxiv__2024__01__12__24301261-141-7-20
    Average 93 stars, based on 1 article reviews
    anti mouse igg goat polyclonal - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    91
    R&D Systems biotin anti mouse cxcl10 goat ab
    Figure 2. Upregulation of <t>CXCL10</t> and MHC class II in human neutrophils in urine during BCG infusion therapy. (a,b) Comprehensive analysis of mRNA expression in urine-derived neutrophils compared to peripheral blood neutrophils. Blood and urine were collected from three patients after one week from the 6th BCG infusion. Comprehensive analysis of mRNA in neutrophils was performed using a DNA tip microarray. (a) Cluster analysis after adjustment and standardiza- tion. The mRNA expression in neutrophils obtained from urine samples (vertical axis) or periph- eral blood (horizontal axis) was analyzed. White lines indicate the thresholds for genes that are upregulated or downregulated > 2-fold between urine- and blood-derived neutrophils. A relatively higher expression in urine-derived neutrophils is indicated using arrows, including expression for CXCR3 ligands (CXCL9 and CXCL10) and MHC class II (HLA-DRB1, HLA-DPA1, and HLA-DQA1). (b) Volcano plot depicting the differentially expressed genes between peripheral blood-derived and urine-derived neutrophils after the 6th BCG infusion. The horizontal axis denotes the fold change in mRNA expression in neutrophils from the urine and blood, while the vertical axis represents the –log10 (p-value) for a t-test of differences in neutrophils from the blood and urine. These data represent the top 6000 genes of the –log10 (p-value). The gene expressions of CXCR3 ligands (CXCL9, CXCL10, and CXCL11) and MHC class II (HLA-DQA2, HLA-DPA1, and HLA-DQA1) were also detected as characteristic features of urine-derived neutrophils (arrows). (c,d) Representative data of intracellular- stained neutrophilic cells obtained via flow cytometric analysis. The CD33+CD15+ neutrophilic cells in the blood (c) or urine (d) samples were obtained from the same patient who was treated with 4th BCG infusions and are presented as CXCL10 MFI (upper panels) and HLA-DR MFI (lower panels). Gray-closed histograms indicate each background staining, and light blue line histograms denote the staining of CXCL10 or HLA-DR. (e–g) Comparison of intracellular expression of (e,f) CXCL10 and (g) HLA-DR in neutrophilic cells from the blood (open circle) and urine (closed circle) samples. These samples were collected after one week from the 2nd to the 6th BCG infusions (after each infusion). (e) ∆CXCL10 MFI was calculated as follows: ∆CXCL10 MFI = (MFI of PE-conjugated anti-CXCL10 mAb staining) −(MFI of PE-conjugated control IgG staining). (f) The neutrophilic cells
    Biotin Anti Mouse Cxcl10 Goat Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+mouse+cxcl10/Mouse+CXCL10%2FIP-10%2FCRG-2+Biotinylated+Antibody/pm38002062-56-109-115
    Average 91 stars, based on 1 article reviews
    biotin anti mouse cxcl10 goat ab - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    95
    Bio-Rad mouse monoclonal igg2a anti cxcl10
    Figure 2. Upregulation of <t>CXCL10</t> and MHC class II in human neutrophils in urine during BCG infusion therapy. (a,b) Comprehensive analysis of mRNA expression in urine-derived neutrophils compared to peripheral blood neutrophils. Blood and urine were collected from three patients after one week from the 6th BCG infusion. Comprehensive analysis of mRNA in neutrophils was performed using a DNA tip microarray. (a) Cluster analysis after adjustment and standardiza- tion. The mRNA expression in neutrophils obtained from urine samples (vertical axis) or periph- eral blood (horizontal axis) was analyzed. White lines indicate the thresholds for genes that are upregulated or downregulated > 2-fold between urine- and blood-derived neutrophils. A relatively higher expression in urine-derived neutrophils is indicated using arrows, including expression for CXCR3 ligands (CXCL9 and CXCL10) and MHC class II (HLA-DRB1, HLA-DPA1, and HLA-DQA1). (b) Volcano plot depicting the differentially expressed genes between peripheral blood-derived and urine-derived neutrophils after the 6th BCG infusion. The horizontal axis denotes the fold change in mRNA expression in neutrophils from the urine and blood, while the vertical axis represents the –log10 (p-value) for a t-test of differences in neutrophils from the blood and urine. These data represent the top 6000 genes of the –log10 (p-value). The gene expressions of CXCR3 ligands (CXCL9, CXCL10, and CXCL11) and MHC class II (HLA-DQA2, HLA-DPA1, and HLA-DQA1) were also detected as characteristic features of urine-derived neutrophils (arrows). (c,d) Representative data of intracellular- stained neutrophilic cells obtained via flow cytometric analysis. The CD33+CD15+ neutrophilic cells in the blood (c) or urine (d) samples were obtained from the same patient who was treated with 4th BCG infusions and are presented as CXCL10 MFI (upper panels) and HLA-DR MFI (lower panels). Gray-closed histograms indicate each background staining, and light blue line histograms denote the staining of CXCL10 or HLA-DR. (e–g) Comparison of intracellular expression of (e,f) CXCL10 and (g) HLA-DR in neutrophilic cells from the blood (open circle) and urine (closed circle) samples. These samples were collected after one week from the 2nd to the 6th BCG infusions (after each infusion). (e) ∆CXCL10 MFI was calculated as follows: ∆CXCL10 MFI = (MFI of PE-conjugated anti-CXCL10 mAb staining) −(MFI of PE-conjugated control IgG staining). (f) The neutrophilic cells
    Mouse Monoclonal Igg2a Anti Cxcl10, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+mouse+cxcl10/Goat+anti+Mouse+IgG2a/pm37891738-61-5-10
    Average 95 stars, based on 1 article reviews
    mouse monoclonal igg2a anti cxcl10 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    Image Search Results


    Figure 2. Upregulation of CXCL10 and MHC class II in human neutrophils in urine during BCG infusion therapy. (a,b) Comprehensive analysis of mRNA expression in urine-derived neutrophils compared to peripheral blood neutrophils. Blood and urine were collected from three patients after one week from the 6th BCG infusion. Comprehensive analysis of mRNA in neutrophils was performed using a DNA tip microarray. (a) Cluster analysis after adjustment and standardiza- tion. The mRNA expression in neutrophils obtained from urine samples (vertical axis) or periph- eral blood (horizontal axis) was analyzed. White lines indicate the thresholds for genes that are upregulated or downregulated > 2-fold between urine- and blood-derived neutrophils. A relatively higher expression in urine-derived neutrophils is indicated using arrows, including expression for CXCR3 ligands (CXCL9 and CXCL10) and MHC class II (HLA-DRB1, HLA-DPA1, and HLA-DQA1). (b) Volcano plot depicting the differentially expressed genes between peripheral blood-derived and urine-derived neutrophils after the 6th BCG infusion. The horizontal axis denotes the fold change in mRNA expression in neutrophils from the urine and blood, while the vertical axis represents the –log10 (p-value) for a t-test of differences in neutrophils from the blood and urine. These data represent the top 6000 genes of the –log10 (p-value). The gene expressions of CXCR3 ligands (CXCL9, CXCL10, and CXCL11) and MHC class II (HLA-DQA2, HLA-DPA1, and HLA-DQA1) were also detected as characteristic features of urine-derived neutrophils (arrows). (c,d) Representative data of intracellular- stained neutrophilic cells obtained via flow cytometric analysis. The CD33+CD15+ neutrophilic cells in the blood (c) or urine (d) samples were obtained from the same patient who was treated with 4th BCG infusions and are presented as CXCL10 MFI (upper panels) and HLA-DR MFI (lower panels). Gray-closed histograms indicate each background staining, and light blue line histograms denote the staining of CXCL10 or HLA-DR. (e–g) Comparison of intracellular expression of (e,f) CXCL10 and (g) HLA-DR in neutrophilic cells from the blood (open circle) and urine (closed circle) samples. These samples were collected after one week from the 2nd to the 6th BCG infusions (after each infusion). (e) ∆CXCL10 MFI was calculated as follows: ∆CXCL10 MFI = (MFI of PE-conjugated anti-CXCL10 mAb staining) −(MFI of PE-conjugated control IgG staining). (f) The neutrophilic cells

    Journal: Biomedicines

    Article Title: Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin .

    doi: 10.3390/biomedicines11113062

    Figure Lengend Snippet: Figure 2. Upregulation of CXCL10 and MHC class II in human neutrophils in urine during BCG infusion therapy. (a,b) Comprehensive analysis of mRNA expression in urine-derived neutrophils compared to peripheral blood neutrophils. Blood and urine were collected from three patients after one week from the 6th BCG infusion. Comprehensive analysis of mRNA in neutrophils was performed using a DNA tip microarray. (a) Cluster analysis after adjustment and standardiza- tion. The mRNA expression in neutrophils obtained from urine samples (vertical axis) or periph- eral blood (horizontal axis) was analyzed. White lines indicate the thresholds for genes that are upregulated or downregulated > 2-fold between urine- and blood-derived neutrophils. A relatively higher expression in urine-derived neutrophils is indicated using arrows, including expression for CXCR3 ligands (CXCL9 and CXCL10) and MHC class II (HLA-DRB1, HLA-DPA1, and HLA-DQA1). (b) Volcano plot depicting the differentially expressed genes between peripheral blood-derived and urine-derived neutrophils after the 6th BCG infusion. The horizontal axis denotes the fold change in mRNA expression in neutrophils from the urine and blood, while the vertical axis represents the –log10 (p-value) for a t-test of differences in neutrophils from the blood and urine. These data represent the top 6000 genes of the –log10 (p-value). The gene expressions of CXCR3 ligands (CXCL9, CXCL10, and CXCL11) and MHC class II (HLA-DQA2, HLA-DPA1, and HLA-DQA1) were also detected as characteristic features of urine-derived neutrophils (arrows). (c,d) Representative data of intracellular- stained neutrophilic cells obtained via flow cytometric analysis. The CD33+CD15+ neutrophilic cells in the blood (c) or urine (d) samples were obtained from the same patient who was treated with 4th BCG infusions and are presented as CXCL10 MFI (upper panels) and HLA-DR MFI (lower panels). Gray-closed histograms indicate each background staining, and light blue line histograms denote the staining of CXCL10 or HLA-DR. (e–g) Comparison of intracellular expression of (e,f) CXCL10 and (g) HLA-DR in neutrophilic cells from the blood (open circle) and urine (closed circle) samples. These samples were collected after one week from the 2nd to the 6th BCG infusions (after each infusion). (e) ∆CXCL10 MFI was calculated as follows: ∆CXCL10 MFI = (MFI of PE-conjugated anti-CXCL10 mAb staining) −(MFI of PE-conjugated control IgG staining). (f) The neutrophilic cells

    Article Snippet: The antibodies used in this study were as follows: fluorescein isothiocyanate (FITC)anti-human CD14 mAb (MφP9), phycoerythrin (PE)-anti-human CD16 mAb (3G8), and allophycocyanin (APC)-anti-human human leukocyte antigen DR isotype (HLA-DR) mAb (G46-6) from BD Biosciences; FITC-anti-human CD15 mAb (HI98), APC- or FITC-antihuman CD16 mAb (3G8), brilliant violet 421-anti-human CD33 mAb (WM53), PE-antihuman CD163 mAb (GHI/61), PE-anti-human CD197 mAb (G043H7), PE-anti-human C-X-C motif chemokine ligand 10 (CXCL10) (J034D6), APC-anti-mouse I-A/I-E mAb (M5/114.15.2), FITC-anti-mouse CD45 mAb (30-F11), PerCP-Cy5.5-anti-mouse Ly6C mAb (HK1.4), brilliant violet 421-anti-mouse Ly6G mAb (1A8), brilliant violet 421-anti-mouse Gr-1 mAb (RB6-8C5), and PE-streptavidin from BioLegend; APC-anti latency-associated peptide-1 (LAP; the N-terminal region of transforming growth factor-β1 precursor) mAb (#27232) and biotin-anti-mouse CXCL10 goat Ab (#BAF466) from R&D systems (Minneapolis, MN, USA); and PE-anti-human GPI-80 mAb (3H9) from MBL (Nagoya, Japan).

    Techniques: Expressing, Derivative Assay, Microarray, Staining, Comparison, Control

    Figure 3. Effect of BCG on CXCL10 and MHC-II expression in human or mice neutrophilic cells in vitro. Human (a,d) or mouse (b,e) peripheral blood was diluted ten-fold in 10% FCS RPMI1640, or mouse bone marrow cells (4 × 106/mL; c,f) were incubated with or without 4 µg/mL of BCG for 20 h. Following incubation, the expression levels of CXCL10 (a–c) and MHC class II (d–f) in human (CD33+CD15+) or mouse neutrophils (CD45+Ly6G+) were analyzed, as described in Figure S2. Statistical significance was calculated with the paired t-test, * p < 0.05 (n = 3). Abbreviations: BCG, Bacillus Calmette–Guérin; CXCL10, chemokine (C-X-C motif) ligand 10; HLA-DR, human major histocompatibility complex class II cell surface receptor; MFI, mean fluorescence intensity; and I-A/I-E, mouse major histocompatibility complex class II cell surface receptor.

    Journal: Biomedicines

    Article Title: Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin .

    doi: 10.3390/biomedicines11113062

    Figure Lengend Snippet: Figure 3. Effect of BCG on CXCL10 and MHC-II expression in human or mice neutrophilic cells in vitro. Human (a,d) or mouse (b,e) peripheral blood was diluted ten-fold in 10% FCS RPMI1640, or mouse bone marrow cells (4 × 106/mL; c,f) were incubated with or without 4 µg/mL of BCG for 20 h. Following incubation, the expression levels of CXCL10 (a–c) and MHC class II (d–f) in human (CD33+CD15+) or mouse neutrophils (CD45+Ly6G+) were analyzed, as described in Figure S2. Statistical significance was calculated with the paired t-test, * p < 0.05 (n = 3). Abbreviations: BCG, Bacillus Calmette–Guérin; CXCL10, chemokine (C-X-C motif) ligand 10; HLA-DR, human major histocompatibility complex class II cell surface receptor; MFI, mean fluorescence intensity; and I-A/I-E, mouse major histocompatibility complex class II cell surface receptor.

    Article Snippet: The antibodies used in this study were as follows: fluorescein isothiocyanate (FITC)anti-human CD14 mAb (MφP9), phycoerythrin (PE)-anti-human CD16 mAb (3G8), and allophycocyanin (APC)-anti-human human leukocyte antigen DR isotype (HLA-DR) mAb (G46-6) from BD Biosciences; FITC-anti-human CD15 mAb (HI98), APC- or FITC-antihuman CD16 mAb (3G8), brilliant violet 421-anti-human CD33 mAb (WM53), PE-antihuman CD163 mAb (GHI/61), PE-anti-human CD197 mAb (G043H7), PE-anti-human C-X-C motif chemokine ligand 10 (CXCL10) (J034D6), APC-anti-mouse I-A/I-E mAb (M5/114.15.2), FITC-anti-mouse CD45 mAb (30-F11), PerCP-Cy5.5-anti-mouse Ly6C mAb (HK1.4), brilliant violet 421-anti-mouse Ly6G mAb (1A8), brilliant violet 421-anti-mouse Gr-1 mAb (RB6-8C5), and PE-streptavidin from BioLegend; APC-anti latency-associated peptide-1 (LAP; the N-terminal region of transforming growth factor-β1 precursor) mAb (#27232) and biotin-anti-mouse CXCL10 goat Ab (#BAF466) from R&D systems (Minneapolis, MN, USA); and PE-anti-human GPI-80 mAb (3H9) from MBL (Nagoya, Japan).

    Techniques: Expressing, In Vitro, Incubation, Immunopeptidomics, Cell Surface Receptor Assay

    Figure 4. Upregulation of CXCL10 and MHC class II in monocytes and neutrophils in peritoneal effusion cells after BCG injections. Mice were injected with B16F10 cells (5 × 104 cells/100 µL/head), and the PECs were collected after two weeks. The PECs induced after one injection of BCG (40 µg/head) after 16 h and the PECs induced after five repeated injections of BCG (40 µg/head) after 16 h from the final injection are presented as “1-shot” and “5-shots”, respectively. These PECs were intracellularly stained with each antibody, and the relative expression (MFI) of CXCL10 and I-A/I-E was analyzed in CD45+Ly6C+ cells and CD45+Ly6G+ cells, respectively. (a–i) Representative flow cytometric analysis of mouse monocytes (Ly6C+ cells) and neutrophils (Ly6G+ cells) via flow cytometry. The (a–c) panels present flow cytometric analysis of the PECs induced 2 weeks after B16F10 cell injection (presented as “Tumor”). The (d–f) panels show representative flow cytometric analysis of the PECs induced 16 h after the administration of BCG (presented as “1-shot). The (g–i) panels indicate representative flow cytometric analyses of the PECs induced via five repeated BCG injections at one-week intervals. The PECs were collected 16 h after the final BCG admin- istration (presented as “5-shots”). The left panels (a,d,g) show CD45+ leukocytes presented with the gates of Ly6C+ cells (monocytic cells) and Ly6G+ cells (neutrophilic cells). (j–l) The number and proportion of myeloid cells (Ly6C+ and Ly6G+ cells) of the PECs. The peritoneal effusion cells obtained after injection of B16F10 cells are presented as “tumor” (open circles). The cells induced 16 h after a single administration of BCG are presented in the group “1-shot” (closed circles). The cells induced via five repeated injections of BCG are presented in the group “5-shots” (closed triangles). The (j) number of the cells in peritoneal fluid were counted using a hemocytometer, and the proportions of (k) Ly6C+ cells and (l) Ly6G+ cells in CD45+ leukocytes were analyzed via flow cytometry. (m–p) The intracellular expression levels of CXCL10 and MHC-II (I-A/I-E) in mouse monocytes (Ly6C+ cells) and neutrophils (Ly6G+ cells) after BCG injection. These PECs were intracellularly stained with each anti- body, and the relative expression (MFI) of (m,n) CXCL10 and (o,p) I-A/I-E was analyzed in (m,o) CD45+Ly6C+ cells and (n,p) CD45+Ly6G+ cells, respectively. Statistical analyses were per- formed using the Kruskal–Wallis test with the Dunn’s post-hoc test. Each bar is presented as the mean of data. * p < 0.05; ** p < 0.01; and ns, not significant. Abbreviations: PECs, peritoneal exudate cells; CXCL10, C-X-C motif chemokine ligand 10; BCG, Bacillus Calmette–Guérin; and MFI, mean fluorescence intensity.

    Journal: Biomedicines

    Article Title: Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin .

    doi: 10.3390/biomedicines11113062

    Figure Lengend Snippet: Figure 4. Upregulation of CXCL10 and MHC class II in monocytes and neutrophils in peritoneal effusion cells after BCG injections. Mice were injected with B16F10 cells (5 × 104 cells/100 µL/head), and the PECs were collected after two weeks. The PECs induced after one injection of BCG (40 µg/head) after 16 h and the PECs induced after five repeated injections of BCG (40 µg/head) after 16 h from the final injection are presented as “1-shot” and “5-shots”, respectively. These PECs were intracellularly stained with each antibody, and the relative expression (MFI) of CXCL10 and I-A/I-E was analyzed in CD45+Ly6C+ cells and CD45+Ly6G+ cells, respectively. (a–i) Representative flow cytometric analysis of mouse monocytes (Ly6C+ cells) and neutrophils (Ly6G+ cells) via flow cytometry. The (a–c) panels present flow cytometric analysis of the PECs induced 2 weeks after B16F10 cell injection (presented as “Tumor”). The (d–f) panels show representative flow cytometric analysis of the PECs induced 16 h after the administration of BCG (presented as “1-shot). The (g–i) panels indicate representative flow cytometric analyses of the PECs induced via five repeated BCG injections at one-week intervals. The PECs were collected 16 h after the final BCG admin- istration (presented as “5-shots”). The left panels (a,d,g) show CD45+ leukocytes presented with the gates of Ly6C+ cells (monocytic cells) and Ly6G+ cells (neutrophilic cells). (j–l) The number and proportion of myeloid cells (Ly6C+ and Ly6G+ cells) of the PECs. The peritoneal effusion cells obtained after injection of B16F10 cells are presented as “tumor” (open circles). The cells induced 16 h after a single administration of BCG are presented in the group “1-shot” (closed circles). The cells induced via five repeated injections of BCG are presented in the group “5-shots” (closed triangles). The (j) number of the cells in peritoneal fluid were counted using a hemocytometer, and the proportions of (k) Ly6C+ cells and (l) Ly6G+ cells in CD45+ leukocytes were analyzed via flow cytometry. (m–p) The intracellular expression levels of CXCL10 and MHC-II (I-A/I-E) in mouse monocytes (Ly6C+ cells) and neutrophils (Ly6G+ cells) after BCG injection. These PECs were intracellularly stained with each anti- body, and the relative expression (MFI) of (m,n) CXCL10 and (o,p) I-A/I-E was analyzed in (m,o) CD45+Ly6C+ cells and (n,p) CD45+Ly6G+ cells, respectively. Statistical analyses were per- formed using the Kruskal–Wallis test with the Dunn’s post-hoc test. Each bar is presented as the mean of data. * p < 0.05; ** p < 0.01; and ns, not significant. Abbreviations: PECs, peritoneal exudate cells; CXCL10, C-X-C motif chemokine ligand 10; BCG, Bacillus Calmette–Guérin; and MFI, mean fluorescence intensity.

    Article Snippet: The antibodies used in this study were as follows: fluorescein isothiocyanate (FITC)anti-human CD14 mAb (MφP9), phycoerythrin (PE)-anti-human CD16 mAb (3G8), and allophycocyanin (APC)-anti-human human leukocyte antigen DR isotype (HLA-DR) mAb (G46-6) from BD Biosciences; FITC-anti-human CD15 mAb (HI98), APC- or FITC-antihuman CD16 mAb (3G8), brilliant violet 421-anti-human CD33 mAb (WM53), PE-antihuman CD163 mAb (GHI/61), PE-anti-human CD197 mAb (G043H7), PE-anti-human C-X-C motif chemokine ligand 10 (CXCL10) (J034D6), APC-anti-mouse I-A/I-E mAb (M5/114.15.2), FITC-anti-mouse CD45 mAb (30-F11), PerCP-Cy5.5-anti-mouse Ly6C mAb (HK1.4), brilliant violet 421-anti-mouse Ly6G mAb (1A8), brilliant violet 421-anti-mouse Gr-1 mAb (RB6-8C5), and PE-streptavidin from BioLegend; APC-anti latency-associated peptide-1 (LAP; the N-terminal region of transforming growth factor-β1 precursor) mAb (#27232) and biotin-anti-mouse CXCL10 goat Ab (#BAF466) from R&D systems (Minneapolis, MN, USA); and PE-anti-human GPI-80 mAb (3H9) from MBL (Nagoya, Japan).

    Techniques: Injection, Staining, Expressing, Cytometry

    Figure 7. CXCL10 and MHC class II expression in neutrophils induced via BCG was inhibited via partial neutrophil depletion using anti-Ly6G mAbs. BCG (40 µg/100 µL/head) was injected into the peritoneal cavity, following which the antibodies (100 µg/50 µL/head; control mAb, open circle; or anti-Ly6G mAb, closed circle) were injected into the

    Journal: Biomedicines

    Article Title: Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin .

    doi: 10.3390/biomedicines11113062

    Figure Lengend Snippet: Figure 7. CXCL10 and MHC class II expression in neutrophils induced via BCG was inhibited via partial neutrophil depletion using anti-Ly6G mAbs. BCG (40 µg/100 µL/head) was injected into the peritoneal cavity, following which the antibodies (100 µg/50 µL/head; control mAb, open circle; or anti-Ly6G mAb, closed circle) were injected into the

    Article Snippet: The antibodies used in this study were as follows: fluorescein isothiocyanate (FITC)anti-human CD14 mAb (MφP9), phycoerythrin (PE)-anti-human CD16 mAb (3G8), and allophycocyanin (APC)-anti-human human leukocyte antigen DR isotype (HLA-DR) mAb (G46-6) from BD Biosciences; FITC-anti-human CD15 mAb (HI98), APC- or FITC-antihuman CD16 mAb (3G8), brilliant violet 421-anti-human CD33 mAb (WM53), PE-antihuman CD163 mAb (GHI/61), PE-anti-human CD197 mAb (G043H7), PE-anti-human C-X-C motif chemokine ligand 10 (CXCL10) (J034D6), APC-anti-mouse I-A/I-E mAb (M5/114.15.2), FITC-anti-mouse CD45 mAb (30-F11), PerCP-Cy5.5-anti-mouse Ly6C mAb (HK1.4), brilliant violet 421-anti-mouse Ly6G mAb (1A8), brilliant violet 421-anti-mouse Gr-1 mAb (RB6-8C5), and PE-streptavidin from BioLegend; APC-anti latency-associated peptide-1 (LAP; the N-terminal region of transforming growth factor-β1 precursor) mAb (#27232) and biotin-anti-mouse CXCL10 goat Ab (#BAF466) from R&D systems (Minneapolis, MN, USA); and PE-anti-human GPI-80 mAb (3H9) from MBL (Nagoya, Japan).

    Techniques: Expressing, Injection, Control